3Marx SO, Marks AR. The development of rapamycin and its application to stent restenosis[J ] . Circulation,2001,104(11) :852.
4Sousa JE,Costa MA,Abizaid A,et al .Lack of neointimal proliferation after implantation of sirolimus - coated stents in human coronary arteries[J]. Circulation,2001,103(2) :192.
5Rensing BJ, Vos J,Smite PC, et al . Coronary restenosis elimination with a sirolimus eluting stent - first European human experience with 6-month angiographic and intravascular ultrasonic follow- up[J]. Eur Heart J ,2001,22(2) :2 125.
6Sousa JE,Costa MA,Abizaid AC,et al .Sustained suppression of neointimal proliferation by sirolimus- eluting stents: one- year angiographic and intravascular ultrasound follow - up[J ] . Circulation, 2001,104(17):2 007.
7Degertekin M,Serruys PW,Foley DP,et al .Persistent inhibition of neointimal hyperplasia after sirolimus- eluting stent implantation: long- term(up to 2 years)clinical, angiographic, and intravascular ultrasound follow - up[J ]. Circulation, 2002,106(13) :1 610.
8Grube E,Bullesfeld L. Initial experience with paclitaxel- coated stents[J ] .J Interv Cardiol,2002,15(6) :471.
10Axel DI, Kunert W, Goggelmann C, et al .Paclitaxel inhibits arterial smooth muscle cell proliferation and migration in vitro and in rive using local drug delivery[J ]. Circulation, 1997,96(2) :636.
二级参考文献47
1Drachman DE,Edelman ER,Seifert P,et al.J Am Coll Cardiol,2000;36(7):2325-2332
1Thyberg J, Hedin U, Sjolund M. Regulation of differentiated properties and proliferation of arterial smooth muscle cells[J ] .Arteriosclerosis, 1990,10(6) : 966.
2Castellot JJ ,Addonizio MC, Rosenberg RD, et al .Cultured endothelial cells produce a heparin like inhibitor of smooth muscle cell growth[J] .J Cell Biol, 1981,90(2): 372.
3Bobik A,Grooms A, Millar JA, et al .Growth factor activity of endothelin on vascular smooth muscle[J] .Am J Physiol, 1990,258(3) : 408.
